LI Chengxiao, LIN Li, WANG Yanfeng. Effects of high flux hemodialysis and low flux hemodialysis for patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 98-101, 106. DOI: 10.7619/jcmp.20210307
Citation: LI Chengxiao, LIN Li, WANG Yanfeng. Effects of high flux hemodialysis and low flux hemodialysis for patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 98-101, 106. DOI: 10.7619/jcmp.20210307

Effects of high flux hemodialysis and low flux hemodialysis for patients with diabetic nephropathy

More Information
  • Received Date: January 20, 2021
  • Available Online: April 20, 2021
  • Published Date: April 14, 2021
  •   Objective  To explore the effects of high flux hemodialysis (HFHD) and low flux hemodialysis (LFHD) on metabolism and renal function in patients with diabetic nephropathy(ND).
      Methods  A total of 60 DN patients were selected and divided into HFHD group and LFHD group according to random number table method, with 30 cases in each group, and the levels of renal function indexes and metabolic indexes were compared between the two groups.
      Results  Before dialysis, there were no significant differences in blood urea nitrogen (BUN), serum creatinine (SCr), β2-microglobulin (β2-MG) between the two groups (P>0.05); after dialysis, the above indexes were significantly higher in the HFHD group than those in the LFHD group(P < 0.05). There were statistically significant differences in hemoglobin (Hb), serum albumin (Alb), total cholesterol (TC), triacylglycerol (TG), high-density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), hypersensitive C-reactive protein (hs-CRP) and blood uric acid (BUA), blood calcium (Ca), phosphorus (P) and parathyroid hormone (PTH), interleukin-6 (IL-6), tumor necrosis factor-α(TNF-α) between the two groups before and after dialysis (P < 0.05). The levels of TC, hs-CRP, P, PTH, IL-6 and TNF-α in the HFHD group after dialysis were significantly lower than those in the LFHD group (P < 0.05), but there were no statistically significant differences in other indexes (P>0.05).
      Conclusion  Compared with LFHD, HFHD in treatment of DN can effectively remove toxin, regulate body metabolism, and significantly improve the patient's renal function and inflammation.
  • [1]
    DE MORAIS R B, DO COUTO MUNIZ V P, NUNES COSTA E, et al. Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition[J]. Biomed Pharmacother, 2018, 107: 1115-1118. doi: 10.1016/j.biopha.2018.08.066
    [2]
    陈玉强, 汪年松. 糖尿病肾病的诊治现状[J]. 中国临床医生杂志, 2020, 48(5): 508-511. doi: 10.3969/j.issn.2095-8552.2020.05.002
    [3]
    许薇, 姚少侠, 苟小林. 血清miRNA-21和miRNA-192表达与糖尿病肾病的相关性研究[J]. 河北医科大学学报, 2019, 40(12): 1460-1464. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX201912026.htm
    [4]
    戴莉敏, 孙婷婷, 崔庆庆, 等. 糖尿病肾病早期微量白蛋白尿病人的综合护理干预[J]. 护理研究, 2020, 34(12): 2098-2104. doi: 10.12102/j.issn.1009-6493.2020.12.008
    [5]
    KAKIO Y, UCHIDA HA, TAKEUCHI H, et al. Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis[J]. Geriatr Gerontol Int, 2018, 18(12): 1597-1602. doi: 10.1111/ggi.13534
    [6]
    赵艳红, 李红梅, 孙阳. 高通量血液透析联合海昆肾喜对糖尿病肾病患者氧化应激及微炎症状态的影响[J]. 中国医药导报, 2020, 17(4): 98-101, 109. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202004019.htm
    [7]
    彭君, 秦鹏, 邢天柱, 等. 血液透析联合血液透析滤过治疗对糖尿病肾病患者心脏结构及功能的影响[J]. 中国老年学杂志, 2019, 39(22): 5427-5429. doi: 10.3969/j.issn.1005-9202.2019.22.011
    [8]
    糖尿病肾病多学科诊治与管理共识专家组. 糖尿病肾病多学科诊治与管理专家共识[J]. 中国临床医生杂志, 2020, 48(5): 522-527. doi: 10.3969/j.issn.2095-8552.2020.05.006
    [9]
    童立鹤, 徐少峰, 程志荣, 等. 维持性血液透析病人抑郁状况及影响因素分析[J]. 蚌埠医学院学报, 2020, 45(6): 781-785. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG202006023.htm
    [10]
    ELBASSUONI E A, AZIZ N M, HABEEB W N. The role of activation of KATP channels on hydrogen sulfide induced renoprotective effect on diabetic nephropathy[J]. J Cell Physiol, 2020, 235(6): 5223-5228. doi: 10.1002/jcp.29403
    [11]
    郑文, 潘少康, 刘东伟, 等. 糖尿病肾病治疗进展[J]. 中华肾脏病杂志, 2020, 36(6): 476-480. doi: 10.3760/cma.j.cn441217-20191023-00089
    [12]
    彭李, 杨建兵. 高通量血液透析对糖尿病肾病患者心功能及血清BNP、cTnI、CK-MB水平的影响[J]. 中国中西医结合肾病杂志, 2020, 21(4): 346-348. doi: 10.3969/j.issn.1009-587X.2020.04.019
    [13]
    母淑娟, 陈静, 李雪, 等. 糖尿病肾病不同分期的中医主证型及其与血清中miR-133、SCr、BUN、Cys-C及CTGF水平相关性分析[J]. 世界中西医结合杂志, 2020, 15(5): 911-914. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX202005031.htm
    [14]
    周建华, 李晓华, 贝鹏剑, 等. 早期2型糖尿病肾病患者血糖波动与氧化应激及尿白蛋白肌酐比、尿β2微球蛋白的相关性研究[J]. 医学研究杂志, 2020, 49(3): 129-133, 145. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ202003031.htm
    [15]
    XU Y, OUYANG C, LYU D, et al. Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway. Biomed Pharmacother[J]. 2020, 125: 109920.
    [16]
    郭海燕, 邢志华, 王丽丽, 等. 沉默GDF15基因表达对高糖诱导的肾小管上皮细胞凋亡和氧化应激的影响[J]. 郑州大学学报: 医学版, 2020, 55(3): 368-373. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202003018.htm
    [17]
    张红霞, 王贵霞, 李振翮, 等. 不同血液透析方式对非糖尿病肾病透析患者胰岛素抵抗的影响[J]. 重庆医学, 2017, 46(29): 4081-4084. doi: 10.3969/j.issn.1671-8348.2017.29.016
  • Related Articles

    [1]WANG Xinzi, QIU Yibo, DENG Yu, YU Siming. Research progress of treatment of vascular calcification in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 144-148. DOI: 10.7619/jcmp.20221784
    [2]WU Guangbiao. Effect of hemodialysis combined with hemoperfusion in the treatment of patients with chronic kidney disease-mineral and bone disorder[J]. Journal of Clinical Medicine in Practice, 2020, 24(10): 110-112. DOI: 10.7619/jcmp.202010028
    [3]GU Jing, ZHAN GHui. Effects of high-flux hemodialysis combined with alprostadil in treating chronic renal failure[J]. Journal of Clinical Medicine in Practice, 2019, (1): 85-88,92. DOI: 10.7619/jcmp.201901023
    [4]ZHANG Ying. Effect of predictive nursing in prevention of noscomial infection in diabetic nephropathy patients with hemodialysis[J]. Journal of Clinical Medicine in Practice, 2018, (6): 36-39. DOI: 10.7619/jcmp.201806011
    [5]HE Pinghong, JIANG Wenyong, SU Fengxian, HU Shanshan, DA Jingjing, ZHA Yan. Clinical effect of high flux hemodialysis foRAECOPD patients complicated with renal insufficiency[J]. Journal of Clinical Medicine in Practice, 2017, (9): 24-27. DOI: 10.7619/jcmp.201709006
    [6]MIAO Changxian, XIE Xianmin, CONG Zhihua. Influence of low calcium dialysate calcium on calcium and phosphorus metabolism and parathyroid hormone in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2017, (3): 29-31. DOI: 10.7619/jcmp.201703009
    [7]TANG Yumei, XU Jixian, LI Gang, WANG Yuan. Influence of high flux hemodialysis on serum β2-microglobulin and parathyroid hormone[J]. Journal of Clinical Medicine in Practice, 2015, (7): 74-76. DOI: 10.7619/jcmp.201507021
    [8]Comparison between on-line hemodiafiltration and high-flux hemodialysis for middle-molecule solues removal[J]. Journal of Clinical Medicine in Practice, 2014, (19): 182-184. DOI: 10.7619/jcmp.201419063
    [9]TANG Xiaojun. Related risk factors of cognitive dysfunction in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2014, (15): 158-159,162. DOI: 10.7619/jcmp.201415055
    [10]YANG Biyu. Preventive effect of nursing intervention on hypoglycemia of hemodialysis in diabetic nephropathy patients[J]. Journal of Clinical Medicine in Practice, 2014, (12): 8-10. DOI: 10.7619/jcmp.201412003

Catalog

    Article views (409) PDF downloads (15) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return